Malignancy risk differs between hidradenitis suppurativa and pilonidal sinus disease - 19/05/25
Doi : 10.1016/j.jaad.2025.01.076
Tara Sholji, MBBS a, Raaisa Islam, MBBS a, b, James Pham, MBBS a, b, Cindy Kok, MD, PhD a, c, John W. Frew, MBBS (Hons), MMed, MS, PhD a, b, ⁎ 
a The Skin Hospital, Darlinghurst, Australia
b University of Sydney, Sydney, Australia
c University of New South Wales, Sydney, Australia
∗Correspondence to: Dr John W. Frew, MBBS (Hons), MMed, MS, PhD, The Skin Hospital Sydney, 121 Crown St, Darlinghurst, New South Wales 2010, AustraliaThe Skin Hospital Sydney121 Crown StDarlinghurstNew South Wales2010Australia
Key words : hidradenitis suppurativa, malignancy, pilonidal sinus disease, screening, squamous cell carcinoma
| Funding sources: JPP is supported by an Australian Government Research Training Program (RTP) scholarship. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Not applicable. |
|
| Data availability statement: Not applicable. |
© 2025
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 92 - N° 6
P. 1381-1382 - juin 2025 Regresar al número
Artículo precedente
- Temporal trends in the prevalence and burden of atopic dermatitis worldwide from 1990 to 2021
- Zhichen Li, Yi Xiao, Xiang Chen, Xiaoyu Gu, Juan Su
- Updated expert opinion guidelines regarding the effects of immunosuppressive agents on patch testing
- Mykayla Sandler, Brandon L. Adler, Amber R. Atwater, Donald V. Belsito, Nina C. Botto, Joel G. DeKoven, Vincent A. DeLeo, Cory A. Dunnick, Joseph F. Fowler, Marie-Claude Houle, Howard I. Maibach, Christen M. Mowad, Margo J. Reeder, James S. Taylor, Erin M. Warshaw, Peggy A. Wu, Jonathan H. Zippin, JiaDe Yu
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?